By DAVID YOUNG Public Relations, Medtronic WARSAW — Medtronic plc announced Monday, Sept. 28, it has acquired Lazarus Effect, a Campbell, Calif.-based, privately-held medical device company focused on acute ischemic stroke products that facilitate the capture and removal of clots. The Lazarus Effect acquisition is an all-cash transaction of $100 million at closing. “With this …read more.